Shares of BioNTech SE (BNTX) rose 6.04% to $275.28 at 12:50 EST on Thursday, after five sequential sessions in a row of gains. NASDAQ Composite is jumping 0.05% to $14,639.99, after two consecutive sessions in a row of gains. This seems, up until now, a somewhat up trend trading session today.
BioNTech SE’s last close was $259.61, 6.31% under its 52-week high of $277.09.
Today’s last reported volume for BioNTech SE is 3345917 which is 8.54% above its average volume of 3082657.
The company’s growth estimates for the present quarter and the next is 2084.4% and 917.8%, respectively.
BioNTech SE’s Revenue
Year-on-year quarterly revenue growth grew by 7294.9%, now sitting on 2.5B for the twelve trailing months.
BioNTech SE’s last week, last month’s, and last quarter’s current volatility was 3.52%, 0.21%, and 3.72%, respectively.
BioNTech SE’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.52% (last week), 2.39% (last month), and 3.72% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
BioNTech SE’s stock is considered to be oversold (<=20).
BioNTech SE’s Stock Yearly Top and Bottom Value
BioNTech SE’s stock is valued at $275.28 at 12:50 EST, below its 52-week high of $277.09 and way higher than its 52-week low of $54.10.
BioNTech SE’s Moving Average
BioNTech SE’s value is way above its 50-day moving average of $224.98 and way higher than its 200-day moving average of $155.71.
More news about BioNTech SE (BNTX).